Arterial Pressure and Stress-Dose Steroids in Cardiac Arrest.
Key facts
- Who runs it
- University of Athens
- Where
- Greece3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- Dec 2025
- Expected to end
- Dec 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Vasopressin Steroids Epinephrine
- Record updated
- 30 March 2025
- Why it stopped
- No funding could be obtained for this study
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Adult patients with vasopressor-requiring inhospital cardiac arrest according to guidelines for resuscitation 2005, defined as:
- epinephrine requirement for ventricular fibrillation/tachycardia
- or asystole, or
- pulseless electrical activity
Who cannot take part
- Pre-arrest treatment with intravenous corticosteroids
- Previous enrollment in or exclusion from the 2 studies included in the analysis
- Terminal illness or do-not resuscitate status
- Cardiac arrest due to exsanguination
- Cardiac arrest before hospital admission
- Age < 18 years
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Early stress-dose steroids are of uncertain efficacy in cardiac arrest. The current authors plan to conduct a pertinent mediation analysis using prospectively collected data from 2 prior randomized clinical trials of in-hospital cardiac arrest. These trials reported positive results on the vasopressin-steroids-epinephrine (VSE) combination. The current analysis is aimed at identifying mediators of the benefit associated with VSE, potentially attributable to its stress-dose steroid subcomponent. Tested mediators will include arterial pressure in the early postresuscitation period (primary), and arterial blood lactate in the early postresuscitation period and renal failure free days (secondary).
The 2 groups in the trial
- Vasopressin Steroids Epinephrine (VSE)
Patients with in-hospital cardiac arrest treated with vasopressin, methylprednisolone, and epinephrine during cardiopulmonary resuscitation, and also with stress-dose hydrocortisone for postresuscitation shock.
Treatment: Vasopressin Steroids Epinephrine
- Control
Patients with in-hospital cardiac arrest treated with normal saline placebo, normal saline placebo, and epinephrine during cardiopulmonary resuscitation, and also with normal saline placebo for postresuscitation shock.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Arterial Pressure and Stress-Dose Steroids in In-hospital Cardiac Arrest: a Mediation Analysis of Prior Randomized Clinical Trial Data.
- Record updated
- 30 March 2025